BioNexus Gene Lab Corp. (NASDAQ:BGLC) Sees Large Drop in Short Interest

BioNexus Gene Lab Corp. (NASDAQ:BGLC) saw a significant decrease in short interest in December. As of December 31st, there was short interest totaling 27,606 shares, a decrease of 31.3% from the December 15th total of 40,210 shares. Based on an average trading volume of 14,763 shares, the short-interest ratio is presently 1.9 days. Approximately 1.2% of the company’s shares are short sold. Approximately 1.2% of the company’s shares are short sold. Based on an average trading volume of 14,763 shares, the short-interest ratio is presently 1.9 days.

BioNexus Gene Lab Trading Down 1.4%

NASDAQ:BGLC traded down $0.05 on Friday, reaching $3.64. The stock had a trading volume of 13,057 shares, compared to its average volume of 8,986. BioNexus Gene Lab has a 12-month low of $2.01 and a 12-month high of $15.60. The company has a 50-day moving average of $4.24 and a 200 day moving average of $5.01. The stock has a market cap of $8.60 million, a P/E ratio of -4.79 and a beta of 5.26.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of BioNexus Gene Lab in a report on Monday, December 29th. One analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has a consensus rating of “Sell”.

About BioNexus Gene Lab

BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers.